CRON · Cronos Group Inc

-

Please sign in to comment on CRON

1 Comment

Admin

4 years, 1 month ago

Cronos Group Inc is currently in a long term downtrend where the price is trading 6.9% below its 200 day moving average.

From a valuation standpoint, the stock is 94.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 70.8.

Cronos Group Inc's total revenue rose by 1009.8% to $17M since the same quarter in the previous year.

Its net income has dropped by 291.5% to $-111M since the same quarter in the previous year.

Finally, its free cash flow grew by 5.7% to $-49M since the same quarter in the previous year.

Based on the above factors, Cronos Group Inc gets an overall score of 3/5.

ISIN	CA22717L1013
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	NASDAQ
CurrencyCode	USD

PE Ratio	16.82
Market Cap	708M
Beta	1.42
Target Price	1.9424
Dividend Yield	None

ABOUT

Cronos Group Inc

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

CRON · Cronos Group Inc

-

Cronos Group Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Cronos Group Inc using a moving average strategy